Chr. Olesen & Co. A/S Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

Estimated Revenue & Financials

  • Chr. Olesen & Co. A/S's estimated annual revenue is currently $12.3M per year.
  • Chr. Olesen & Co. A/S's estimated revenue per employee is $201,000

Employee Data

  • Chr. Olesen & Co. A/S has 61 Employees.
  • Chr. Olesen & Co. A/S grew their employee count by 24% last year.
  • Chr. Olesen & Co. A/S currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Blue Earth Diag...
$18.7M9333%N/A
Biotest Pharmac...
$115.8M576N/AN/A
Beaphar UK
$6.8M346%N/A
Vitaflo Interna...
$13.7M68-14%N/A
Sinclair Pharma
$49.6M24719%N/A
Ironwood Pharma...
N/A428N/AN/A
Redmond and Gre...
$12.5M6219%N/A
Trifecta Clinic...
$13.1M653%N/A
Sparhawk Labora...
$6.8M3413%N/A
Adelphi Communi...
$15.5M778%N/A
Missing a competitor? Contribute!?
Submit

Chr. Olesen is a distribution company. We strive to be perceived as the best link between manufactures and customers in distributing high-quality ingredients to the feed, food and pharmaceutical industries all over the world. Reliability is the quality assurance of everything we do.

keywords:N/A

61

Number of Employees

$12.3M

Revenue (est)

1

Current Jobs

24%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Chr. Olesen & Co. A/S News

09/05/2019 - New Market Report on Denmark Vermouth Market, Estimating ...

New Market Report on Denmark Vermouth Market, Estimating for Years 2019-2026, and Prominent Players are, Carlsberg Group Chr. Olesen ...

04/04/2019 - Knight Files Management Information Circular, Warns ...

... of Spepharm B.V., Bionpharma Inc., CoreRx, Inc., Leon Nanodrugs GmbH, Pharmaceutics International, Inc. and Chr. Olesen Synthesis A/S

08/06/2019 - Portable Medical Devices Market 2019-2025 increasing ...

The global portable medical devices market which was represented a CAGR of approximately +9% in the midst of the estimate time span of ...